IN2013MU03567A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03567A
IN2013MU03567A IN3567MU2013A IN2013MU03567A IN 2013MU03567 A IN2013MU03567 A IN 2013MU03567A IN 3567MU2013 A IN3567MU2013 A IN 3567MU2013A IN 2013MU03567 A IN2013MU03567 A IN 2013MU03567A
Authority
IN
India
Prior art keywords
relates
delivery system
active ingredients
pharmaceutical active
novel
Prior art date
Application number
Other languages
English (en)
Inventor
Vandana Bharat Patravale;
Soniya Ankitkumar Jain;
Medha Joshi;
Priyanka Suresh Prabhu;
Shobhona Sharma;
Sulabha Pathak;
Original Assignee
Patravale Vandana Bharat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patravale Vandana Bharat filed Critical Patravale Vandana Bharat
Priority to IN3567MU2013 priority Critical patent/IN2013MU03567A/en
Publication of IN2013MU03567A publication Critical patent/IN2013MU03567A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN3567MU2013 2013-11-13 2013-11-13 IN2013MU03567A (cg-RX-API-DMAC7.html)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN3567MU2013 IN2013MU03567A (cg-RX-API-DMAC7.html) 2013-11-13 2013-11-13

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3567MU2013 IN2013MU03567A (cg-RX-API-DMAC7.html) 2013-11-13 2013-11-13

Publications (1)

Publication Number Publication Date
IN2013MU03567A true IN2013MU03567A (cg-RX-API-DMAC7.html) 2015-07-31

Family

ID=54397569

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3567MU2013 IN2013MU03567A (cg-RX-API-DMAC7.html) 2013-11-13 2013-11-13

Country Status (1)

Country Link
IN (1) IN2013MU03567A (cg-RX-API-DMAC7.html)

Similar Documents

Publication Publication Date Title
EA201200937A1 (ru) Твердая лекарственная форма тикагрелора
PH12014501984A1 (en) Pharmaceutical compositions comprising metformin and a dpp-4 inhibitor or a sglt-2 inhibitor
MX2022009352A (es) Sal de hemisulfato de nucleotido para el tratamiento del virus de hepatitis c.
MX2017000080A (es) Conjugados y particulas direccionados y formulaciones de estos.
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
BR112015018087A8 (pt) composto, composição farmacêutica e uso
HK1221418A1 (zh) 释放修饰药物的水凝胶-连接的前药
PH12015500713A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
CR10822A (es) Formulacion en polvo del valganciclovir
HK1223304A1 (zh) 包含二甲双胍和二氢槲皮素的药物组合及其用於治疗癌症的用途
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
MX2017013636A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas.
HK1203815A1 (en) Pharmaceutical compositions and methods for their preparation
WO2016044839A3 (en) Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
CY1124635T1 (el) Ξηρες φαρμακευτικες συνθεσεις που περιεχουν νανοσωματιδια ενεργου παραγοντα δεσμευμενα σε σωματιδια φορεα
MX363699B (es) Producto de comicronizacion que comprende acetato de ulipristal.
WO2013104892A8 (en) Application of high dose compounds via inhalation
WO2016030899A8 (en) Methods of treating amyotrophic lateral scleroses
EA201501164A1 (ru) Твердая фармацевтическая лекарственная форма
UY35771A (es) Tienouracil-carboxamidas cíclicas y su uso
MY184630A (en) Tylosin derivatives and method for preparation thereof
MX364652B (es) Formulacion farmaceutica que comprende ciclesonida.
BR112014024033A8 (pt) Formulação vesicular, método para o tratamento da rosácea e uso de um ou mais fosfo, sulfolipídios e surfactantes
MX2015009891A (es) Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion.